Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2022. Go to the latest filing (Q3 2026)

19.9B USDQ4 2022
Total value of stock positions
19.9B USD
Positions
75
Share of the ten largest
41.8%

The ten largest positions Q4 2022

  1. Visa Inc. 6.0%▲ +8.2%
  2. Amazon 5.3%▲ +34.4%
  3. Elevance Health 4.8%▼ −19.9%
  4. McKesson Corporation 4.2%▼ −15.5%
  5. Microsoft 4.1%▼ −2.3%
  6. Chubb Limited 4.0%▼ −0.4%
  7. Roivant Sciences Ltd 3.5%unchanged
  8. UnitedHealth Group 3.4%▲ +263.7%
  9. GE Aerospace 3.3%▼ −39.6%
  10. Api Group Corp 3.2%unchanged
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q4 2022

Positions Q4 2022 per 13F filing, 75 of 75
Symbol Weight Shares Reported value Change Held since
AMZN Amazon 5.3% 12,481,958 1.0B USD +34.4% increased Q2 2015 31 quarters
MSFT Microsoft 4.1% 3,429,127 822.4M USD −2.3% reduced Q2 2016 27 quarters
V Visa Inc. 6.0% 5,784,971 1.2B USD +8.2% increased Q3 2016 26 quarters
Catalent Inc 0.3% 1,424,388 64.1M USD −14.9% reduced Q1 2018 20 quarters
BSX Boston Scientific 2.2% 9,528,593 440.9M USD −41.0% reduced Q3 2018 18 quarters
Adaptive Biotechnologies Cor 1.2% 29,993,708 229.2M USD unchanged Q2 2019 15 quarters
Bridgebio Pharma Inc 1.0% 26,620,991 202.9M USD unchanged Q2 2019 15 quarters
FTV Fortive 1.3% 3,890,600 250.0M USD −36.0% reduced Q3 2019 14 quarters
Molina Healthcare Inc 1.0% 588,208 194.2M USD +44.6% increased Q3 2019 14 quarters
Guardant Health Inc 0.6% 4,107,644 111.7M USD +7.1% increased Q3 2019 14 quarters
CB Chubb Limited 4.0% 3,580,128 789.8M USD −0.4% reduced Q1 2020 12 quarters
Api Group Corp 3.2% 33,819,567 636.1M USD unchanged Q2 2020 11 quarters
TMO Thermo Fisher Scientific 2.3% 839,526 462.3M USD +41.4% increased Q2 2020 11 quarters
Royalty Pharma PLC 2.0% 10,008,511 395.5M USD −8.0% reduced Q2 2020 11 quarters
Karuna Therapeutics Inc 1.2% 1,183,736 232.6M USD +16.7% increased Q3 2020 10 quarters
Inhibrx Inc 0.8% 6,639,199 163.6M USD +25.1% increased Q3 2020 10 quarters
PODD Insulet Corporation 0.4% 268,052 78.9M USD −56.1% reduced Q3 2020 10 quarters
GE GE Aerospace 3.3% 7,775,177 651.5M USD −39.6% reduced Q4 2020 9 quarters
META Meta Platforms 1.4% 2,387,730 287.3M USD −55.4% reduced Q4 2020 9 quarters
Acadia Healthcare Company In 1.3% 3,161,114 260.2M USD +6.8% increased Q4 2020 9 quarters
4D Molecular Therapeutics In 0.4% 3,937,914 87.5M USD unchanged Q4 2020 9 quarters
Kinnate Biopharma Inc < 0.1% 1,820,462 11.1M USD unchanged Q4 2020 9 quarters
AMP Ameriprise Financial 2.6% 1,647,855 513.1M USD −8.7% reduced Q1 2021 8 quarters
CRL Charles River Laboratories 0.6% 515,168 112.3M USD −21.8% reduced Q1 2021 8 quarters
Zai Lab Ltd 0.3% 1,973,597 60.6M USD −24.5% reduced Q1 2021 8 quarters
Edgewise Therapeutics Inc 0.2% 4,409,146 39.4M USD unchanged Q1 2021 8 quarters
Pharvaris N V 0.2% 3,231,923 36.4M USD +29.4% increased Q1 2021 8 quarters
Intellia Therapeutics Inc 0.4% 2,021,410 70.5M USD +7.0% increased Q2 2021 7 quarters
Day One Biopharmaceuticals I 0.2% 1,558,563 33.5M USD unchanged Q2 2021 7 quarters
Talaris Therapeutics Inc < 0.1% 3,289,617 3.4M USD unchanged Q2 2021 7 quarters
Hdfc Bank Ltd 2.9% 8,570,740 586.3M USD −11.8% reduced Q3 2021 6 quarters
UBER Uber 1.0% 7,939,999 196.4M USD −51.6% reduced Q3 2021 6 quarters
Ginkgo Bioworks Holdings Inc 0.5% 63,085,126 106.6M USD −38.1% reduced Q3 2021 6 quarters
Rallybio Corp 0.1% 4,194,777 27.6M USD unchanged Q3 2021 6 quarters
Roivant Sciences Ltd 3.5% 88,238,700 705.0M USD unchanged Q4 2021 5 quarters
Biomarin Pharmaceutical Inc 2.7% 5,273,620 545.8M USD +3.4% increased Q4 2021 5 quarters
XYZ Block, Inc. 1.4% 4,483,754 281.8M USD −15.6% reduced Q4 2021 5 quarters
BEKE KE Holdings 0.6% 8,084,334 112.9M USD +107.6% increased Q4 2021 5 quarters
IFF International Flavors & Fragrances 0.2% 439,360 46.1M USD −88.2% reduced Q4 2021 5 quarters
Lianbio < 0.1% 3,564,173 5.8M USD unchanged Q4 2021 5 quarters
ELV Elevance Health 4.8% 1,872,176 960.4M USD −19.9% reduced Q1 2022 4 quarters
MA Mastercard 3.0% 1,709,228 594.3M USD −3.5% reduced Q1 2022 4 quarters
Amylyx Pharmaceuticals Inc 0.9% 4,634,606 171.2M USD −19.7% reduced Q1 2022 4 quarters
Unum Group 0.7% 3,431,274 140.8M USD −32.4% reduced Q1 2022 4 quarters
Inspire Med Sys Inc 0.7% 549,793 138.5M USD −13.2% reduced Q1 2022 4 quarters
DG Dollar General 0.4% 310,848 76.5M USD −87.2% reduced Q1 2022 4 quarters
PGR Progressive Corporation 0.2% 336,861 43.7M USD −54.3% reduced Q1 2022 4 quarters
MCK McKesson Corporation 4.2% 2,204,418 826.9M USD −15.5% reduced Q2 2022 3 quarters
INTU Intuit 2.3% 1,181,697 459.9M USD +2.1% increased Q2 2022 3 quarters
MU Micron Technology 2.1% 8,358,708 417.8M USD +54.4% increased Q2 2022 3 quarters
Rh 1.0% 748,344 200.0M USD +80.4% increased Q2 2022 3 quarters
Shockwave Med Inc 0.2% 164,607 33.8M USD +4.6% increased Q2 2022 3 quarters
Pepgen Inc 0.1% 1,544,631 20.7M USD −13.9% reduced Q2 2022 3 quarters
Verastem Inc < 0.1% 9,224,000 3.7M USD unchanged Q2 2022 3 quarters
UNH UnitedHealth Group 3.4% 1,267,703 672.1M USD +263.7% increased Q3 2022 2 quarters
Rogers Comms B 1.0% 4,375,144 204.8M USD +29.5% increased Q3 2022 2 quarters
CDNS Cadence Design Systems 0.9% 1,134,301 182.2M USD +87.3% increased Q3 2022 2 quarters
Valvoline Inc 0.8% 4,876,780 159.2M USD −16.6% reduced Q3 2022 2 quarters
CLX Clorox 0.5% 768,839 107.9M USD +26.7% increased Q3 2022 2 quarters
CRWD CrowdStrike 0.4% 699,948 73.7M USD +146.2% increased Q3 2022 2 quarters
Trevi Therapeutics Inc < 0.1% 4,400,000 8.5M USD unchanged Q3 2022 2 quarters
CSX CSX Corporation 2.4% 15,548,123 481.7M USD new Q4 2022 1 quarter
FTNT Fortinet 1.8% 7,126,827 348.4M USD new Q4 2022 1 quarter
Seagate Technology Hldngs Pl 1.6% 6,198,933 326.1M USD new Q4 2022 1 quarter
Brookfield Corp 1.1% 7,262,078 228.5M USD new Q4 2022 1 quarter
LI Li Auto 0.9% 9,090,065 185.4M USD new Q4 2022 1 quarter
AIG American International Group 0.8% 2,590,026 163.8M USD new Q4 2022 1 quarter
Equitable HLDGS Inc 0.8% 5,212,460 149.6M USD new Q4 2022 1 quarter
AMD Advanced Micro Devices 0.6% 1,905,600 123.4M USD new Q4 2022 1 quarter
ALB Albemarle Corporation 0.4% 337,339 73.2M USD new Q4 2022 1 quarter
Kbr Inc 0.3% 1,077,300 56.9M USD new Q4 2022 1 quarter
Capri Holdings Limited 0.2% 810,479 46.5M USD new Q4 2022 1 quarter
Regal Rexnord Corporation 0.2% 362,403 43.5M USD new Q4 2022 1 quarter
Newamsterdam Pharma Company 0.2% 3,753,828 39.5M USD new Q4 2022 1 quarter
Farfetch Ltd 0.2% 6,771,235 32.0M USD new Q4 2022 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 75.2M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Guardant Health Inc principal 120.0M USD 75.2M USD

Breakdown by sector

  • Financials 18.0%
  • Health Care 17.9%
  • Technology 12.2%
  • Industrials 7.9%
  • Consumer Discretionary 5.3%
  • Communication Services 1.4%
  • Consumer Staples 0.9%
  • Materials 0.6%
  • not in our coverage 35.7%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close